GlassScriptPhysician profile
Neeru Arora
NPI 1982668141
$2,416.24
in general payments reported to CMS, 2019-2025
16 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $214 · 2021: $237 · 2022: $468 · 2023: $400 · 2024: $362 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.22 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,249.68 | 2019-2025 | Lokelma, Farxiga |
| Mallinckrodt Enterprises LLC | $314.02 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $300.99 | 2021-2025 | |
| Opko Pharmaceuticals, LLC | $149.23 | 2019-2021 | |
| Horizon Therapeutics Plc | $84.57 | 2020-2022 | |
| Glaxosmithkline, LLC. | $48.59 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.43 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $45.66 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $36.27 | 2022 | |
| Eisai INC. | $32.36 | 2024 | |
| Xeris Pharmaceuticals, INC. | $24.71 | 2025 | Recorlev |
| Novartis Pharmaceuticals Corporation | $22.95 | 2021 | |
| Travere Therapeutics, INC. | $21.02 | 2023 | |
| Amgen INC. | $14.52 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.10 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeru Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.